Hodgkin lymphoma

News
Assessing Frequency of Secondary Malignancies in Survivors of Hodgkin Lymphoma
06/17/2020
A single institution study conducted at the Ospedale Oncologico di Riferimento Regionale (Italy) provided data on the cumulative incidence of secondary malignancies after treatment for Hodgkin lymphoma.
A single institution study conducted at the Ospedale Oncologico di Riferimento Regionale (Italy) provided data on the cumulative incidence of secondary malignancies after treatment for Hodgkin lymphoma.
A single institution study...
06/17/2020
Journal of Clinical Pathways
News
Comparative Effectiveness of Monotherapies for Relapsed, Refractory Hodgkin Lymphoma
05/14/2020
In patients with relapsed or refractory classic Hodgkin lymphoma, pembrolizumab may be superior to brentuximab vedotin and provide statistically significant and clinically meaningful improvement in PFS across all subgroups.
In patients with relapsed or refractory classic Hodgkin lymphoma, pembrolizumab may be superior to brentuximab vedotin and provide statistically significant and clinically meaningful improvement in PFS across all subgroups.
In patients with relapsed or...
05/14/2020
Journal of Clinical Pathways
Research in Review
Early PET Scan Improves Outcomes for Patients With Hodgkin Lymphoma
06/08/2017
JCP Editors
Response to positron emission tomography (PET) scan after two cycles of standard treatment allows for early treatment adaption for patients with early-stage Hodgkin lymphoma, according to research published in the...
Response to positron emission tomography (PET) scan after two cycles of standard treatment allows for early treatment adaption for patients with early-stage Hodgkin lymphoma, according to research published in the...
...
06/08/2017
Journal of Clinical Pathways
Research in Review
Radiation Therapy Significantly Increases Survival in Type of B-Cell Malignancy
05/31/2017
JCP Editors
Patients with Hodgkin lymphoma who are treated with radiation therapy are more likely to survive the disease than those not treated with radiation therapy, according to a recent study published in Anticancer Research...
Patients with Hodgkin lymphoma who are treated with radiation therapy are more likely to survive the disease than those not treated with radiation therapy, according to a recent study published in Anticancer Research...
...
05/31/2017
Journal of Clinical Pathways
Research in Review
Increased Risk of Secondary Cancer for Survivors of Hodgkin Lymphoma
05/19/2017
JCP Editors
Survivors of Hodgkin lymphoma with a family history of cancer have a 1.3-fold higher risk of developing a second cancer, according to research published in the Journal of Clinical Oncology (May...
Survivors of Hodgkin lymphoma with a family history of cancer have a 1.3-fold higher risk of developing a second cancer, according to research published in the Journal of Clinical Oncology (May...
...
05/19/2017
Journal of Clinical Pathways
Research in Review
Risk-Adapted Therapy Reduces Treatment Toxicity for Patients With Hodgkin Lymphoma
05/19/2017
JCP Editors
A combined chemotherapy approach may eliminate the toxic effects of radiation therapy in children and young adults with Hodgkin lymphoma, according to early results of a study that will be presented at the 2017 ASCO...
A combined chemotherapy approach may eliminate the toxic effects of radiation therapy in children and young adults with Hodgkin lymphoma, according to early results of a study that will be presented at the 2017 ASCO...
A...
05/19/2017
Journal of Clinical Pathways
Research in Review
Risk-Adapted Therapy Recommended for Patients With Hodgkin Lymphoma
04/27/2017
JCP Editors
Long-term follow-up data from multiple studies support the current risk-adapted therapeutic strategies in early-stage Hodgkin lymphoma, according to research published in the Journal of Clinical Oncology (published...
Long-term follow-up data from multiple studies support the current risk-adapted therapeutic strategies in early-stage Hodgkin lymphoma, according to research published in the Journal of Clinical Oncology (published...
...
04/27/2017
Journal of Clinical Pathways
Adolescent Hodgkin Lymphoma Patients Not Receiving Optimal Follow-up Care
01/18/2016
JCP Editors
Adolescent and young adult (AYAs) survivors of Hodgkin lymphoma may not be receiving the recommended post-treatment care, according to a recent study. Cancer is the leading cause of death in AYAs, and Hodgkin...
Adolescent and young adult (AYAs) survivors of Hodgkin lymphoma may not be receiving the recommended post-treatment care, according to a recent study. Cancer is the leading cause of death in AYAs, and Hodgkin...
...
01/18/2016
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use